Results 161 to 170 of about 6,074,393 (210)

Ebola Virus Disease Preparedness in Subnational Health Systems: A Readiness Assessment of Jinja District, Uganda. [PDF]

J Trop Med
Oposhia J, Kungu JM, Nantamu PD, Namayanja J, Okuyo CAB, Mulowoza M, Kabali K, Edson K, Olupot-Olupot P.   +8 more
europepmc   +1 more source

Discontinuous EBOV RNA synthesis events in patients with Ebola virus disease and their relationship to viral load and outcome of infection. [PDF]

J Virol
Dong X, Garcia-Dorival I, Rickett NY, Bosworth A, Smither S, Dowall S, Carroll MW, Matthews DA, Laws TR, Digard P, Hiscox JA.   +10 more
europepmc   +1 more source

Seven Strategies Implemented in Response to the 16th Ebola Virus Disease Outbreak in the Democratic Republic of Congo: Lessons Learned over a Three-Month Period. [PDF]

Viruses
Mwamba DK, Angendu KB, Diouf W, Mikobi MC, Leonard O, Kalala D, Ntumba N, Kakule D, Kayembe DK, Sana E, Kabasele B, Katya J, Montoyo A, Serra B, Bulambo H, Otshudiema J, Kapanga S, Balayulu O, Muya J, Kamangu E, Kitenge R, Tshapenda G, Kasita C, Keita M, Kabasubabo FK, Kombe J, Mossoko M, Ngandu CB, Manianga C, Moullec G, Zarowsky C, Akilimali PZ.   +31 more
europepmc   +1 more source

Understanding the pathogenesis of uveitis in Ebola virus disease survivors: an observational cohort and cross-sectional study protocol for clinical, molecular virologic and immunologic characterisation. [PDF]

BMJ Open
Hartley CD, Linderman S, Fashina T, Ward L, Drews-Botsch C, Pratt C, Kuthyar S, Fernandes AF, Huang Y, Choo C, Nguyen N, Carag J, Morgan J, Kraft CS, Hewlett A, Brett-Major D, Schieffelin JS, Garry RF, Grant D, Justin GA, Conrady CD, Smith JR, Hayek BR, Balendra S, Acharya N, Doan T, Legand A, Formenty P, Zeng X, Conteh I, Vandy MJ, Harrison-Williams L, Mustapha J, Koroma Z, Wiley MR, Crozier I, Mwanza JC, Shantha JG, Ahmed R, Yeh S, SMILE and EVICT-VR Investigator Study Groups.   +40 more
europepmc   +1 more source

Clinical and Occupational Predictors of Mortality in Ebola Virus Disease: A Commentary from the Democratic Republic of Congo (2018-2020). [PDF]

Infect Dis Rep
Milambo JPM, Businge CB.
europepmc   +1 more source

Misconceptions about Ebola Virus Disease among Residents of Calabar, Cross River State, Nigeria: A Mixed-Method Approach. [PDF]

Niger Med J
Bisong EM, Ayuk AE, Asibong IU, Asibong UE, Okokon IB, Monjok E.   +5 more
europepmc   +1 more source

Extending mental health support to the survivors of Ebola virus disease by overcoming challenges. [PDF]

Germs
Shrivastava SR, Bobhate PS.
europepmc   +1 more source

Treatment of Ebola Virus Disease: From Serotherapy to the Use of Monoclonal Antibodies. [PDF]

Antibodies (Basel)
Shcherbakov DN, Isaeva AA, Mustaev EA.
europepmc   +1 more source

Five-year immunogenicity and safety follow-up of the PREVAC randomized Trial of Vaccines for Zaire Ebola Virus Disease

Beavogui AH, Doumbia S, Kieh M, Leigh B, Sow S, Lhomme E, Ben-Farhat S, Dubois Cauwelaert N, Roy C, Diouf W, Idrissa S, Diarra S, Millimouno NP, Diallo FA, Kamara M, Pratt D, Dicko I, Kennedy SB, Espérou H, Choi EM, Kpetigo AD, D’Ortenzio E, Diallo A, Lancrey-javal S, Hamzé B, Schwimmer C, Wiedemann A, Ayouba A, Peeters M, Lane HC, Higgs E, Watson-Jones D, Yazdanpanah Y, Greenwood B, Richert L, Levy Y, PREVAC study Team.   +36 more
europepmc   +1 more source